Top Page
China Reinsurance (Group) Corp. Class H
(1508)
China Reinsurance (Group) Corp. Class H (1508) vs. iShares MSCI Hong Kong ETF (EWH)
China Reinsurance (Group) Corp. Class H Business Overview & Revenue Model
China Reinsurance (Group) Corp. Class H Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 103.25B | 85.54B | 94.96B | 88.27B | 163.95B | 168.10B |
| Gross Profit | 103.25B | 85.54B | 94.96B | 80.06B | 163.95B | 168.10B |
| EBITDA | -85.92B | 17.04B | 3.28B | 1.85B | 10.38B | 10.25B |
| Net Income | 11.07B | 10.56B | 5.65B | -324.64M | 5.95B | 5.71B |
Balance Sheet | ||||||
| Total Assets | 516.45B | 508.35B | 459.73B | 424.73B | 499.80B | 453.58B |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 13.01B | 10.30B | 10.97B | 18.74B | 10.22B |
| Total Debt | 13.25B | 13.97B | 15.43B | 17.96B | 27.46B | 27.79B |
| Total Liabilities | 399.66B | 395.68B | 357.55B | 327.24B | 397.71B | 350.68B |
| Stockholders Equity | 107.10B | 103.26B | 93.25B | 86.02B | 92.71B | 93.03B |
Cash Flow | ||||||
| Free Cash Flow | 14.99B | 9.91B | 15.86B | 11.31B | 9.12B | 32.34B |
| Operating Cash Flow | 15.45B | 10.35B | 16.29B | 11.71B | 9.56B | 33.24B |
| Investing Cash Flow | -4.27B | -18.56B | -14.83B | -6.80B | -15.57B | -47.34B |
| Financing Cash Flow | -5.93B | 4.62B | 999.20M | -12.20B | 14.01B | 7.96B |
China Reinsurance (Group) Corp. Class H Technical Analysis
China Reinsurance (Group) Corp. Class H Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$51.03B | 6.91 | 9.76% | 5.80% | 8.20% | 42.29% | |
71 Outperform | €67.12B | 5.62 | 11.12% | 3.32% | 2.54% | 17.80% | |
71 Outperform | $65.16B | 7.97 | 10.74% | 1.94% | 23.64% | 36.32% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
61 Neutral | €85.82B | 14.03 | 5.22% | 2.61% | 30.38% | 2.63% | |
58 Neutral | €27.66B | 18.40 | 6.00% | ― | -2.69% | -68.97% | |
51 Neutral | €15.95B | 20.05 | 7.22% | ― | 19.01% | 64.43% |
China Reinsurance (Group) Corp. Class H Corporate Events
China Reinsurance (Group) Corporation has announced the closure of its register of members in preparation for its second extraordinary general meeting (EGM) of 2025, scheduled for December 23, 2025. This closure will take place from December 18 to December 23, 2025, during which no share transfers will be processed. Shareholders listed on the register by December 23, 2025, will be eligible to attend and vote at the EGM. The meeting will address various resolutions, details of which will be communicated to shareholders in due course.
China Reinsurance (Group) Corporation announced the successful conclusion of its first extraordinary general meeting of 2025, where several key resolutions were passed. These included amendments to the Articles of Association, the Rules of Procedures for both the General Meeting and the Board of Directors, and the abolishment of the Board of Supervisors. The resolutions were overwhelmingly supported by shareholders, indicating strong backing for the company’s strategic changes. This meeting reflects the company’s ongoing efforts to streamline governance and enhance operational efficiency, potentially impacting its industry positioning and stakeholder relations positively.
China Reinsurance (Group) Corporation announced the successful issuance of RMB4.0 billion in capital supplementary bonds by its subsidiary, China Re P&C, in the National Interbank Bond Market. These ten-year fixed-rate bonds, with conditional redemption rights and varying coupon rates, aim to bolster the subsidiary’s capital, improve solvency, and support sustainable business growth.
China Reinsurance (Group) Corporation has announced its first extraordinary general meeting (EGM) of 2025, scheduled for November 28th in Beijing. The meeting will address several key resolutions, including amendments to the Articles of Association and the Rules of Procedures, as well as the abolishment of the Board of Supervisors. Additionally, the meeting will cover the remuneration of directors and supervisors for the year 2023. The announcement reflects the company’s ongoing efforts to streamline its governance structure and enhance operational efficiency, potentially impacting its strategic direction and stakeholder engagement.
China Reinsurance (Group) Corporation has announced the proposed abolishment of its Board of Supervisors, with the functions and powers being transferred to the audit committee of the Board. This change is subject to approval at the shareholders’ general meeting and aims to streamline corporate governance in line with regulatory requirements, potentially impacting the company’s operational oversight and stakeholder engagement.
China Reinsurance (Group) Corporation has announced the closure of its register of members to confirm shareholder entitlements for its first extraordinary general meeting of 2025, scheduled for November 28. This closure, from November 25 to November 28, 2025, will affect share transfers, and shareholders are required to ensure their registration by November 24 to participate and vote at the meeting.
China Reinsurance (Group) Corporation has announced proposed amendments to its Articles of Association to align with the new Company Law of the People’s Republic of China and updated regulatory requirements. These changes include the removal of the Board of Supervisors, with its functions being transferred to the audit committee, and adjustments to the responsibilities of the chief compliance officer. The amendments are pending approval by the shareholders and the insurance regulatory authority, and aim to streamline corporate governance and compliance processes.
China Reinsurance (Group) Corporation announced the resignation of Mr. Liu Yuanzhang from his roles as assistant to the president, secretary to the Board, and joint company secretary due to work re-arrangement, effective 31 October 2025. Mr. Liu confirmed no disagreements with the Board, and Ms. Ng Sau Mei will continue as the sole company secretary, ensuring compliance with Hong Kong Stock Exchange regulations.
China Reinsurance (Group) Corporation has released its solvency and financial performance indicators for the third quarter of 2025, highlighting a strong solvency position with a core solvency adequacy ratio of 324% at the group level. The company’s subsidiaries also demonstrate robust solvency ratios, reflecting a stable financial position. The group reported significant insurance income and net profits across its subsidiaries, indicating a solid operational performance. These results underscore the company’s strong market positioning and its ability to meet regulatory requirements, providing confidence to shareholders and investors.
China Reinsurance (Group) Corporation announced the unaudited financial data and solvency statement for its subsidiary, China Re P&C, for the nine months ended 30 September 2025. The company disclosed a comprehensive financial position with total assets amounting to RMB146.19 billion. The announcement highlights the company’s commitment to transparency and regulatory compliance by regularly disclosing financial data and solvency statements, which is crucial for maintaining stakeholder trust and ensuring market stability.
China Reinsurance (Group) Corporation announced the unaudited financial data and solvency statement for its subsidiary, China Re Life, for the nine months ending September 30, 2025. The company successfully issued RMB5.0 billion in capital supplementary bonds, necessitating quarterly disclosure of financial and solvency reports. This move is expected to enhance transparency and strengthen the company’s financial position, potentially impacting its market standing and stakeholder confidence.
China Reinsurance (Group) Corporation has announced a change in its agent for the acceptance of service of process in Hong Kong due to the retirement of Ms. Luo Yawei. Effective from September 26, 2025, Mr. Zhou Jun will replace Ms. Luo Yawei as the new Process Agent, ensuring continuity in compliance with Hong Kong’s regulatory requirements.
China Reinsurance (Group) Corporation announced that its subsidiary, China Re P&C, has received regulatory approvals to issue 10-year redeemable capital supplementary bonds up to RMB4.0 billion in the National Interbank Bond Market. This move is expected to enhance the company’s solvency and support the sustainable growth of its business operations.
China Reinsurance (Group) Corporation announced significant leadership changes with the resignation of Mr. He Chunlei as chairman of the board and executive director due to reaching the statutory retirement age. Mr. Zhuang Qianzhi has been appointed as the new chairman of the board, pending approval from the National Financial Regulatory Administration. These changes are expected to influence the company’s strategic direction and operational leadership, potentially impacting its market positioning and stakeholder relations.
China Reinsurance (Group) Corporation announced the composition of its board of directors, which includes eight members with specific roles and functions. The board has established five specialized committees to oversee different aspects of the company’s operations, highlighting a structured approach to governance and strategic oversight.
China Reinsurance (Group) Corporation announced the approval of Mr. Keung Yui Fai as an independent non-executive director by the National Financial Regulatory Administration. This approval enables the company to comply with the Hong Kong Stock Exchange’s requirements for board composition, ensuring it has the requisite number of independent non-executive directors. The appointment also addresses previous regulatory compliance issues related to board composition and committee leadership, enhancing the company’s governance structure.
China Reinsurance (Group) Corporation has announced the composition of its board of directors, which includes a mix of executive, non-executive, and independent non-executive directors. The board has established five specialized committees to oversee various aspects of the company’s operations, indicating a structured approach to governance and risk management.